No, DSIP is typically administered through injection for research purposes
TRIUMPH-4 (December 2025) TRIUMPH-1 (May 21, 2026) Semaglutide STEP-1 Trial What Nearly Double the Weight Loss Means in Practice For a patient starting at 250 lbs: These numbers come from separate trials with different populations not a direct head-to-head comparison
Realistically, you're looking at 3 months before you'd see early signs of response, and 6 months for a meaningful assessment
For example, your fatigue might be driven by low vitamin D or another cause rather than B12
It must include: patient selection, long-term adherence, functional monitoring beyond kilograms lost, pharmacovigilance, continuity of care, and, above all, affordability and equitable access
Phase 3 trials sometimes produce slightly different results than Phase 2 due to differences in patient selection, study duration, and statistical methodology